nodes	percent_of_prediction	percent_of_DWPC	metapath
Propranolol—SLC22A2—Cladribine—multiple sclerosis	0.133	0.209	CbGbCtD
Propranolol—CYP2D6—Fingolimod—multiple sclerosis	0.0518	0.0813	CbGbCtD
Propranolol—ABCB1—Methylprednisolone—multiple sclerosis	0.0354	0.0556	CbGbCtD
Propranolol—CYP1A1—Dexamethasone—multiple sclerosis	0.0343	0.0538	CbGbCtD
Propranolol—HTR1B—trigeminal nucleus—multiple sclerosis	0.0332	0.54	CbGeAlD
Propranolol—CYP3A4—Fingolimod—multiple sclerosis	0.033	0.0517	CbGbCtD
Propranolol—CYP3A7—Dexamethasone—multiple sclerosis	0.0275	0.0431	CbGbCtD
Propranolol—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0275	0.0431	CbGbCtD
Propranolol—CYP2C19—Prednisone—multiple sclerosis	0.0266	0.0417	CbGbCtD
Propranolol—ABCB1—Mitoxantrone—multiple sclerosis	0.0259	0.0406	CbGbCtD
Propranolol—ABCB1—Betamethasone—multiple sclerosis	0.023	0.0362	CbGbCtD
Propranolol—ABCB1—Prednisolone—multiple sclerosis	0.0227	0.0357	CbGbCtD
Propranolol—ABCB1—Prednisone—multiple sclerosis	0.0215	0.0337	CbGbCtD
Propranolol—CYP3A4—Methylprednisolone—multiple sclerosis	0.0212	0.0333	CbGbCtD
Propranolol—CYP3A5—Dexamethasone—multiple sclerosis	0.0206	0.0323	CbGbCtD
Propranolol—CYP2C19—Dexamethasone—multiple sclerosis	0.0166	0.0261	CbGbCtD
Propranolol—CYP3A4—Triamcinolone—multiple sclerosis	0.0161	0.0252	CbGbCtD
Propranolol—CYP3A4—Mitoxantrone—multiple sclerosis	0.0155	0.0243	CbGbCtD
Propranolol—CYP3A4—Betamethasone—multiple sclerosis	0.0138	0.0217	CbGbCtD
Propranolol—CYP3A4—Prednisolone—multiple sclerosis	0.0136	0.0214	CbGbCtD
Propranolol—ABCB1—Dexamethasone—multiple sclerosis	0.0134	0.021	CbGbCtD
Propranolol—CYP3A4—Prednisone—multiple sclerosis	0.0129	0.0202	CbGbCtD
Propranolol—CYP2D6—Dexamethasone—multiple sclerosis	0.0126	0.0198	CbGbCtD
Propranolol—ABCB1—Methotrexate—multiple sclerosis	0.0108	0.0169	CbGbCtD
Propranolol—HTR1B—trigeminal nerve—multiple sclerosis	0.00872	0.142	CbGeAlD
Propranolol—CYP3A4—Dexamethasone—multiple sclerosis	0.00803	0.0126	CbGbCtD
Propranolol—Carvedilol—SELE—multiple sclerosis	0.00231	0.512	CrCbGaD
Propranolol—Carvedilol—VCAM1—multiple sclerosis	0.00221	0.488	CrCbGaD
Propranolol—HTR1B—brainstem—multiple sclerosis	0.00137	0.0222	CbGeAlD
Propranolol—HTR1A—brainstem—multiple sclerosis	0.0011	0.0179	CbGeAlD
Propranolol—ORM1—spinal cord—multiple sclerosis	0.000907	0.0147	CbGeAlD
Propranolol—HTR1B—midbrain—multiple sclerosis	0.000871	0.0142	CbGeAlD
Propranolol—HTR1B—spinal cord—multiple sclerosis	0.00085	0.0138	CbGeAlD
Propranolol—ORM1—nervous system—multiple sclerosis	0.000764	0.0124	CbGeAlD
Propranolol—ORM1—central nervous system—multiple sclerosis	0.000735	0.012	CbGeAlD
Propranolol—HTR1B—nervous system—multiple sclerosis	0.000716	0.0117	CbGeAlD
Propranolol—HTR1A—midbrain—multiple sclerosis	0.000703	0.0114	CbGeAlD
Propranolol—HTR1B—central nervous system—multiple sclerosis	0.000689	0.0112	CbGeAlD
Propranolol—HTR1A—spinal cord—multiple sclerosis	0.000686	0.0112	CbGeAlD
Propranolol—ADRB1—nervous system—multiple sclerosis	0.000674	0.011	CbGeAlD
Propranolol—ADRB1—central nervous system—multiple sclerosis	0.000649	0.0106	CbGeAlD
Propranolol—CYP2D6—brainstem—multiple sclerosis	0.000599	0.00974	CbGeAlD
Propranolol—HTR1A—nervous system—multiple sclerosis	0.000578	0.0094	CbGeAlD
Propranolol—HTR1A—central nervous system—multiple sclerosis	0.000556	0.00905	CbGeAlD
Propranolol—HTR1B—brain—multiple sclerosis	0.000547	0.00891	CbGeAlD
Propranolol—HTR1A—cerebellum—multiple sclerosis	0.000544	0.00885	CbGeAlD
Propranolol—ADRB1—brain—multiple sclerosis	0.000515	0.00838	CbGeAlD
Propranolol—HTR1A—brain—multiple sclerosis	0.000442	0.00719	CbGeAlD
Propranolol—CYP1A1—nervous system—multiple sclerosis	0.000434	0.00707	CbGeAlD
Propranolol—CYP1A1—central nervous system—multiple sclerosis	0.000418	0.00681	CbGeAlD
Propranolol—ABCB1—retina—multiple sclerosis	0.000416	0.00676	CbGeAlD
Propranolol—Cardiac arrest—Prednisone—multiple sclerosis	0.000395	0.00181	CcSEcCtD
Propranolol—Mood swings—Prednisone—multiple sclerosis	0.000394	0.0018	CcSEcCtD
Propranolol—Hypersensitivity—Cladribine—multiple sclerosis	0.000384	0.00176	CcSEcCtD
Propranolol—Visual impairment—Prednisolone—multiple sclerosis	0.000381	0.00174	CcSEcCtD
Propranolol—Asthenia—Cladribine—multiple sclerosis	0.000374	0.00171	CcSEcCtD
Propranolol—Bradycardia—Triamcinolone—multiple sclerosis	0.000371	0.00169	CcSEcCtD
Propranolol—Bradycardia—Methylprednisolone—multiple sclerosis	0.00037	0.00169	CcSEcCtD
Propranolol—Dermatitis exfoliative—Methotrexate—multiple sclerosis	0.000368	0.00168	CcSEcCtD
Propranolol—Visual disturbance—Methotrexate—multiple sclerosis	0.000367	0.00168	CcSEcCtD
Propranolol—Cough—Mitoxantrone—multiple sclerosis	0.000367	0.00168	CcSEcCtD
Propranolol—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000366	0.00167	CcSEcCtD
Propranolol—Convulsion—Mitoxantrone—multiple sclerosis	0.000364	0.00166	CcSEcCtD
Propranolol—Hallucination—Methylprednisolone—multiple sclerosis	0.000361	0.00165	CcSEcCtD
Propranolol—Pharyngitis—Triamcinolone—multiple sclerosis	0.000361	0.00165	CcSEcCtD
Propranolol—Anaphylactoid reaction—Methotrexate—multiple sclerosis	0.000359	0.00164	CcSEcCtD
Propranolol—Diarrhoea—Cladribine—multiple sclerosis	0.000357	0.00163	CcSEcCtD
Propranolol—Lethargy—Methotrexate—multiple sclerosis	0.000355	0.00162	CcSEcCtD
Propranolol—Visual impairment—Methylprednisolone—multiple sclerosis	0.00035	0.0016	CcSEcCtD
Propranolol—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000347	0.00158	CcSEcCtD
Propranolol—Dizziness—Cladribine—multiple sclerosis	0.000345	0.00158	CcSEcCtD
Propranolol—Erythema—Prednisolone—multiple sclerosis	0.000345	0.00158	CcSEcCtD
Propranolol—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000343	0.00157	CcSEcCtD
Propranolol—Infection—Mitoxantrone—multiple sclerosis	0.000341	0.00156	CcSEcCtD
Propranolol—Cardiac disorder—Methylprednisolone—multiple sclerosis	0.000337	0.00154	CcSEcCtD
Propranolol—Bradycardia—Dexamethasone—multiple sclerosis	0.000336	0.00154	CcSEcCtD
Propranolol—Bradycardia—Betamethasone—multiple sclerosis	0.000336	0.00154	CcSEcCtD
Propranolol—Neutropenia—Prednisone—multiple sclerosis	0.000336	0.00154	CcSEcCtD
Propranolol—Body temperature increased—Azathioprine—multiple sclerosis	0.000335	0.00153	CcSEcCtD
Propranolol—Abdominal pain—Azathioprine—multiple sclerosis	0.000335	0.00153	CcSEcCtD
Propranolol—Skin disorder—Mitoxantrone—multiple sclerosis	0.000333	0.00152	CcSEcCtD
Propranolol—CYP1A1—brain—multiple sclerosis	0.000332	0.0054	CbGeAlD
Propranolol—Irritability—Methotrexate—multiple sclerosis	0.000332	0.00152	CcSEcCtD
Propranolol—Vomiting—Cladribine—multiple sclerosis	0.000332	0.00152	CcSEcCtD
Propranolol—Erectile dysfunction—Prednisone—multiple sclerosis	0.000331	0.00151	CcSEcCtD
Propranolol—Mood swings—Methotrexate—multiple sclerosis	0.000329	0.0015	CcSEcCtD
Propranolol—Rash—Cladribine—multiple sclerosis	0.000329	0.0015	CcSEcCtD
Propranolol—Hallucination—Dexamethasone—multiple sclerosis	0.000329	0.0015	CcSEcCtD
Propranolol—Hallucination—Betamethasone—multiple sclerosis	0.000329	0.0015	CcSEcCtD
Propranolol—Dermatitis—Cladribine—multiple sclerosis	0.000329	0.0015	CcSEcCtD
Propranolol—Depression—Prednisone—multiple sclerosis	0.00032	0.00146	CcSEcCtD
Propranolol—CYP3A4—nervous system—multiple sclerosis	0.000319	0.00519	CbGeAlD
Propranolol—Visual impairment—Dexamethasone—multiple sclerosis	0.000318	0.00145	CcSEcCtD
Propranolol—Visual impairment—Betamethasone—multiple sclerosis	0.000318	0.00145	CcSEcCtD
Propranolol—Mental disorder—Methylprednisolone—multiple sclerosis	0.000318	0.00145	CcSEcCtD
Propranolol—Erythema—Triamcinolone—multiple sclerosis	0.000317	0.00145	CcSEcCtD
Propranolol—Erythema—Methylprednisolone—multiple sclerosis	0.000316	0.00145	CcSEcCtD
Propranolol—CYP2D6—nervous system—multiple sclerosis	0.000314	0.0051	CbGeAlD
Propranolol—Toxic epidermal necrolysis—Methotrexate—multiple sclerosis	0.000313	0.00143	CcSEcCtD
Propranolol—Hypersensitivity—Azathioprine—multiple sclerosis	0.000312	0.00143	CcSEcCtD
Propranolol—Nausea—Cladribine—multiple sclerosis	0.00031	0.00142	CcSEcCtD
Propranolol—Vertigo—Prednisolone—multiple sclerosis	0.00031	0.00142	CcSEcCtD
Propranolol—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000308	0.00141	CcSEcCtD
Propranolol—CYP3A4—central nervous system—multiple sclerosis	0.000307	0.00499	CbGeAlD
Propranolol—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000306	0.0014	CcSEcCtD
Propranolol—Somnolence—Mitoxantrone—multiple sclerosis	0.000305	0.00139	CcSEcCtD
Propranolol—CYP2D6—central nervous system—multiple sclerosis	0.000302	0.00491	CbGeAlD
Propranolol—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000302	0.00138	CcSEcCtD
Propranolol—ABCB1—medulla oblongata—multiple sclerosis	0.0003	0.00489	CbGeAlD
Propranolol—Convulsion—Prednisolone—multiple sclerosis	0.000299	0.00136	CcSEcCtD
Propranolol—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000298	0.00136	CcSEcCtD
Propranolol—Fatigue—Mitoxantrone—multiple sclerosis	0.000296	0.00135	CcSEcCtD
Propranolol—CYP2D6—cerebellum—multiple sclerosis	0.000295	0.0048	CbGeAlD
Propranolol—Constipation—Mitoxantrone—multiple sclerosis	0.000293	0.00134	CcSEcCtD
Propranolol—Pain—Mitoxantrone—multiple sclerosis	0.000293	0.00134	CcSEcCtD
Propranolol—Bradycardia—Prednisone—multiple sclerosis	0.000293	0.00134	CcSEcCtD
Propranolol—Alopecia—Dexamethasone—multiple sclerosis	0.000292	0.00133	CcSEcCtD
Propranolol—Alopecia—Betamethasone—multiple sclerosis	0.000292	0.00133	CcSEcCtD
Propranolol—Diarrhoea—Azathioprine—multiple sclerosis	0.00029	0.00133	CcSEcCtD
Propranolol—Erythema—Betamethasone—multiple sclerosis	0.000288	0.00131	CcSEcCtD
Propranolol—Erythema—Dexamethasone—multiple sclerosis	0.000288	0.00131	CcSEcCtD
Propranolol—Hallucination—Prednisone—multiple sclerosis	0.000286	0.00131	CcSEcCtD
Propranolol—Vertigo—Triamcinolone—multiple sclerosis	0.000285	0.0013	CcSEcCtD
Propranolol—Vertigo—Methylprednisolone—multiple sclerosis	0.000284	0.0013	CcSEcCtD
Propranolol—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000281	0.00129	CcSEcCtD
Propranolol—Neutropenia—Methotrexate—multiple sclerosis	0.000281	0.00128	CcSEcCtD
Propranolol—Dizziness—Azathioprine—multiple sclerosis	0.00028	0.00128	CcSEcCtD
Propranolol—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.00028	0.00128	CcSEcCtD
Propranolol—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000277	0.00126	CcSEcCtD
Propranolol—Cough—Triamcinolone—multiple sclerosis	0.000277	0.00126	CcSEcCtD
Propranolol—Convulsion—Triamcinolone—multiple sclerosis	0.000275	0.00125	CcSEcCtD
Propranolol—ABCB1—midbrain—multiple sclerosis	0.000275	0.00447	CbGeAlD
Propranolol—Convulsion—Methylprednisolone—multiple sclerosis	0.000274	0.00125	CcSEcCtD
Propranolol—Urticaria—Mitoxantrone—multiple sclerosis	0.000272	0.00124	CcSEcCtD
Propranolol—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000271	0.00124	CcSEcCtD
Propranolol—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000271	0.00124	CcSEcCtD
Propranolol—Vomiting—Azathioprine—multiple sclerosis	0.00027	0.00123	CcSEcCtD
Propranolol—ABCB1—spinal cord—multiple sclerosis	0.000268	0.00436	CbGeAlD
Propranolol—Infestation NOS—Methotrexate—multiple sclerosis	0.000268	0.00122	CcSEcCtD
Propranolol—Infestation—Methotrexate—multiple sclerosis	0.000268	0.00122	CcSEcCtD
Propranolol—Rash—Azathioprine—multiple sclerosis	0.000267	0.00122	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000267	0.00122	CcSEcCtD
Propranolol—Dermatitis—Azathioprine—multiple sclerosis	0.000267	0.00122	CcSEcCtD
Propranolol—Depression—Methotrexate—multiple sclerosis	0.000267	0.00122	CcSEcCtD
Propranolol—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000265	0.00121	CcSEcCtD
Propranolol—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000259	0.00118	CcSEcCtD
Propranolol—Vertigo—Dexamethasone—multiple sclerosis	0.000258	0.00118	CcSEcCtD
Propranolol—Vertigo—Betamethasone—multiple sclerosis	0.000258	0.00118	CcSEcCtD
Propranolol—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000258	0.00118	CcSEcCtD
Propranolol—Infection—Triamcinolone—multiple sclerosis	0.000257	0.00117	CcSEcCtD
Propranolol—Infection—Methylprednisolone—multiple sclerosis	0.000256	0.00117	CcSEcCtD
Propranolol—Insomnia—Prednisolone—multiple sclerosis	0.000254	0.00116	CcSEcCtD
Propranolol—Alopecia—Prednisone—multiple sclerosis	0.000254	0.00116	CcSEcCtD
Propranolol—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000253	0.00116	CcSEcCtD
Propranolol—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000253	0.00115	CcSEcCtD
Propranolol—Paraesthesia—Prednisolone—multiple sclerosis	0.000253	0.00115	CcSEcCtD
Propranolol—Mental disorder—Prednisone—multiple sclerosis	0.000252	0.00115	CcSEcCtD
Propranolol—Nausea—Azathioprine—multiple sclerosis	0.000252	0.00115	CcSEcCtD
Propranolol—Skin disorder—Methylprednisolone—multiple sclerosis	0.000251	0.00115	CcSEcCtD
Propranolol—Erythema—Prednisone—multiple sclerosis	0.00025	0.00114	CcSEcCtD
Propranolol—Agranulocytosis—Methotrexate—multiple sclerosis	0.00025	0.00114	CcSEcCtD
Propranolol—Convulsion—Dexamethasone—multiple sclerosis	0.000249	0.00114	CcSEcCtD
Propranolol—Convulsion—Betamethasone—multiple sclerosis	0.000249	0.00114	CcSEcCtD
Propranolol—Asthenia—Mitoxantrone—multiple sclerosis	0.000246	0.00112	CcSEcCtD
Propranolol—Pain—Prednisolone—multiple sclerosis	0.00024	0.0011	CcSEcCtD
Propranolol—CYP2D6—brain—multiple sclerosis	0.00024	0.0039	CbGeAlD
Propranolol—Pharyngitis—Methotrexate—multiple sclerosis	0.000239	0.00109	CcSEcCtD
Propranolol—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000235	0.00107	CcSEcCtD
Propranolol—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000235	0.00107	CcSEcCtD
Propranolol—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000235	0.00107	CcSEcCtD
Propranolol—Insomnia—Triamcinolone—multiple sclerosis	0.000234	0.00107	CcSEcCtD
Propranolol—Insomnia—Methylprednisolone—multiple sclerosis	0.000233	0.00107	CcSEcCtD
Propranolol—Infection—Dexamethasone—multiple sclerosis	0.000233	0.00107	CcSEcCtD
Propranolol—Infection—Betamethasone—multiple sclerosis	0.000233	0.00107	CcSEcCtD
Propranolol—Paraesthesia—Triamcinolone—multiple sclerosis	0.000232	0.00106	CcSEcCtD
Propranolol—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000232	0.00106	CcSEcCtD
Propranolol—Visual impairment—Methotrexate—multiple sclerosis	0.000232	0.00106	CcSEcCtD
Propranolol—Dyspnoea—Triamcinolone—multiple sclerosis	0.000231	0.00105	CcSEcCtD
Propranolol—Nervous system disorder—Betamethasone—multiple sclerosis	0.00023	0.00105	CcSEcCtD
Propranolol—Nervous system disorder—Dexamethasone—multiple sclerosis	0.00023	0.00105	CcSEcCtD
Propranolol—Agitation—Prednisone—multiple sclerosis	0.00023	0.00105	CcSEcCtD
Propranolol—Dyspepsia—Triamcinolone—multiple sclerosis	0.000228	0.00104	CcSEcCtD
Propranolol—Erythema multiforme—Methotrexate—multiple sclerosis	0.000227	0.00104	CcSEcCtD
Propranolol—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000227	0.00104	CcSEcCtD
Propranolol—ABCB1—nervous system—multiple sclerosis	0.000226	0.00367	CbGeAlD
Propranolol—Vertigo—Prednisone—multiple sclerosis	0.000225	0.00103	CcSEcCtD
Propranolol—Urticaria—Prednisolone—multiple sclerosis	0.000223	0.00102	CcSEcCtD
Propranolol—Cardiac disorder—Methotrexate—multiple sclerosis	0.000223	0.00102	CcSEcCtD
Propranolol—Fatigue—Triamcinolone—multiple sclerosis	0.000223	0.00102	CcSEcCtD
Propranolol—Fatigue—Methylprednisolone—multiple sclerosis	0.000222	0.00102	CcSEcCtD
Propranolol—Pain—Triamcinolone—multiple sclerosis	0.000221	0.00101	CcSEcCtD
Propranolol—Vomiting—Mitoxantrone—multiple sclerosis	0.000218	0.000996	CcSEcCtD
Propranolol—ABCB1—central nervous system—multiple sclerosis	0.000217	0.00354	CbGeAlD
Propranolol—Convulsion—Prednisone—multiple sclerosis	0.000217	0.000992	CcSEcCtD
Propranolol—Rash—Mitoxantrone—multiple sclerosis	0.000216	0.000988	CcSEcCtD
Propranolol—Dermatitis—Mitoxantrone—multiple sclerosis	0.000216	0.000987	CcSEcCtD
Propranolol—Alopecia—Methotrexate—multiple sclerosis	0.000212	0.000971	CcSEcCtD
Propranolol—ABCB1—cerebellum—multiple sclerosis	0.000212	0.00346	CbGeAlD
Propranolol—Insomnia—Dexamethasone—multiple sclerosis	0.000212	0.00097	CcSEcCtD
Propranolol—Insomnia—Betamethasone—multiple sclerosis	0.000212	0.00097	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000212	0.000968	CcSEcCtD
Propranolol—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000211	0.000964	CcSEcCtD
Propranolol—Paraesthesia—Betamethasone—multiple sclerosis	0.000211	0.000963	CcSEcCtD
Propranolol—Paraesthesia—Dexamethasone—multiple sclerosis	0.000211	0.000963	CcSEcCtD
Propranolol—Mental disorder—Methotrexate—multiple sclerosis	0.000211	0.000963	CcSEcCtD
Propranolol—Erythema—Methotrexate—multiple sclerosis	0.000209	0.000957	CcSEcCtD
Propranolol—Hypersensitivity—Prednisolone—multiple sclerosis	0.000207	0.000947	CcSEcCtD
Propranolol—Dyspepsia—Betamethasone—multiple sclerosis	0.000207	0.000944	CcSEcCtD
Propranolol—Dyspepsia—Dexamethasone—multiple sclerosis	0.000207	0.000944	CcSEcCtD
Propranolol—Urticaria—Triamcinolone—multiple sclerosis	0.000205	0.000939	CcSEcCtD
Propranolol—Urticaria—Methylprednisolone—multiple sclerosis	0.000205	0.000937	CcSEcCtD
Propranolol—Body temperature increased—Triamcinolone—multiple sclerosis	0.000204	0.000934	CcSEcCtD
Propranolol—Anaphylactic shock—Prednisone—multiple sclerosis	0.000204	0.000934	CcSEcCtD
Propranolol—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000204	0.000932	CcSEcCtD
Propranolol—Decreased appetite—Dexamethasone—multiple sclerosis	0.000204	0.000932	CcSEcCtD
Propranolol—Decreased appetite—Betamethasone—multiple sclerosis	0.000204	0.000932	CcSEcCtD
Propranolol—Nausea—Mitoxantrone—multiple sclerosis	0.000204	0.000931	CcSEcCtD
Propranolol—Infection—Prednisone—multiple sclerosis	0.000203	0.000928	CcSEcCtD
Propranolol—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000203	0.000926	CcSEcCtD
Propranolol—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000203	0.000926	CcSEcCtD
Propranolol—Fatigue—Betamethasone—multiple sclerosis	0.000202	0.000925	CcSEcCtD
Propranolol—Fatigue—Dexamethasone—multiple sclerosis	0.000202	0.000925	CcSEcCtD
Propranolol—Pain—Betamethasone—multiple sclerosis	0.000201	0.000917	CcSEcCtD
Propranolol—Pain—Dexamethasone—multiple sclerosis	0.000201	0.000917	CcSEcCtD
Propranolol—Nervous system disorder—Prednisone—multiple sclerosis	0.0002	0.000916	CcSEcCtD
Propranolol—Skin disorder—Prednisone—multiple sclerosis	0.000199	0.000907	CcSEcCtD
Propranolol—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000192	0.000877	CcSEcCtD
Propranolol—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000192	0.000877	CcSEcCtD
Propranolol—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000191	0.000871	CcSEcCtD
Propranolol—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00019	0.000869	CcSEcCtD
Propranolol—Vertigo—Methotrexate—multiple sclerosis	0.000188	0.000859	CcSEcCtD
Propranolol—Urticaria—Dexamethasone—multiple sclerosis	0.000186	0.000852	CcSEcCtD
Propranolol—Urticaria—Betamethasone—multiple sclerosis	0.000186	0.000852	CcSEcCtD
Propranolol—Dizziness—Prednisolone—multiple sclerosis	0.000186	0.00085	CcSEcCtD
Propranolol—Asthenia—Triamcinolone—multiple sclerosis	0.000186	0.000848	CcSEcCtD
Propranolol—Body temperature increased—Dexamethasone—multiple sclerosis	0.000186	0.000848	CcSEcCtD
Propranolol—Body temperature increased—Betamethasone—multiple sclerosis	0.000186	0.000848	CcSEcCtD
Propranolol—Abdominal pain—Betamethasone—multiple sclerosis	0.000186	0.000848	CcSEcCtD
Propranolol—Abdominal pain—Dexamethasone—multiple sclerosis	0.000186	0.000848	CcSEcCtD
Propranolol—Asthenia—Methylprednisolone—multiple sclerosis	0.000185	0.000846	CcSEcCtD
Propranolol—Insomnia—Prednisone—multiple sclerosis	0.000185	0.000845	CcSEcCtD
Propranolol—Paraesthesia—Prednisone—multiple sclerosis	0.000184	0.000839	CcSEcCtD
Propranolol—Cough—Methotrexate—multiple sclerosis	0.000183	0.000835	CcSEcCtD
Propranolol—Convulsion—Methotrexate—multiple sclerosis	0.000181	0.000829	CcSEcCtD
Propranolol—Dyspepsia—Prednisone—multiple sclerosis	0.00018	0.000822	CcSEcCtD
Propranolol—Decreased appetite—Prednisone—multiple sclerosis	0.000178	0.000812	CcSEcCtD
Propranolol—Rash—Prednisolone—multiple sclerosis	0.000177	0.00081	CcSEcCtD
Propranolol—Dermatitis—Prednisolone—multiple sclerosis	0.000177	0.00081	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000177	0.000809	CcSEcCtD
Propranolol—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000177	0.000807	CcSEcCtD
Propranolol—Fatigue—Prednisone—multiple sclerosis	0.000176	0.000805	CcSEcCtD
Propranolol—Constipation—Prednisone—multiple sclerosis	0.000175	0.000799	CcSEcCtD
Propranolol—ABCB1—brain—multiple sclerosis	0.000173	0.00281	CbGeAlD
Propranolol—Dizziness—Triamcinolone—multiple sclerosis	0.000171	0.000782	CcSEcCtD
Propranolol—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000171	0.000781	CcSEcCtD
Propranolol—Dizziness—Methylprednisolone—multiple sclerosis	0.000171	0.00078	CcSEcCtD
Propranolol—Infection—Methotrexate—multiple sclerosis	0.00017	0.000776	CcSEcCtD
Propranolol—Asthenia—Dexamethasone—multiple sclerosis	0.000168	0.00077	CcSEcCtD
Propranolol—Asthenia—Betamethasone—multiple sclerosis	0.000168	0.00077	CcSEcCtD
Propranolol—Nervous system disorder—Methotrexate—multiple sclerosis	0.000167	0.000766	CcSEcCtD
Propranolol—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000167	0.000764	CcSEcCtD
Propranolol—Nausea—Prednisolone—multiple sclerosis	0.000167	0.000764	CcSEcCtD
Propranolol—Skin disorder—Methotrexate—multiple sclerosis	0.000166	0.000758	CcSEcCtD
Propranolol—Vomiting—Triamcinolone—multiple sclerosis	0.000164	0.000752	CcSEcCtD
Propranolol—Vomiting—Methylprednisolone—multiple sclerosis	0.000164	0.00075	CcSEcCtD
Propranolol—Rash—Triamcinolone—multiple sclerosis	0.000163	0.000745	CcSEcCtD
Propranolol—Dermatitis—Triamcinolone—multiple sclerosis	0.000163	0.000745	CcSEcCtD
Propranolol—Rash—Methylprednisolone—multiple sclerosis	0.000163	0.000744	CcSEcCtD
Propranolol—Dermatitis—Methylprednisolone—multiple sclerosis	0.000163	0.000743	CcSEcCtD
Propranolol—Urticaria—Prednisone—multiple sclerosis	0.000162	0.000742	CcSEcCtD
Propranolol—Abdominal pain—Prednisone—multiple sclerosis	0.000162	0.000738	CcSEcCtD
Propranolol—Body temperature increased—Prednisone—multiple sclerosis	0.000162	0.000738	CcSEcCtD
Propranolol—Diarrhoea—Dexamethasone—multiple sclerosis	0.000161	0.000734	CcSEcCtD
Propranolol—Diarrhoea—Betamethasone—multiple sclerosis	0.000161	0.000734	CcSEcCtD
Propranolol—Dizziness—Dexamethasone—multiple sclerosis	0.000155	0.000709	CcSEcCtD
Propranolol—Dizziness—Betamethasone—multiple sclerosis	0.000155	0.000709	CcSEcCtD
Propranolol—Insomnia—Methotrexate—multiple sclerosis	0.000154	0.000706	CcSEcCtD
Propranolol—Nausea—Triamcinolone—multiple sclerosis	0.000154	0.000702	CcSEcCtD
Propranolol—Paraesthesia—Methotrexate—multiple sclerosis	0.000153	0.000701	CcSEcCtD
Propranolol—Nausea—Methylprednisolone—multiple sclerosis	0.000153	0.000701	CcSEcCtD
Propranolol—Dyspnoea—Methotrexate—multiple sclerosis	0.000152	0.000696	CcSEcCtD
Propranolol—Somnolence—Methotrexate—multiple sclerosis	0.000152	0.000694	CcSEcCtD
Propranolol—Hypersensitivity—Prednisone—multiple sclerosis	0.000151	0.000688	CcSEcCtD
Propranolol—Dyspepsia—Methotrexate—multiple sclerosis	0.00015	0.000687	CcSEcCtD
Propranolol—Vomiting—Dexamethasone—multiple sclerosis	0.000149	0.000682	CcSEcCtD
Propranolol—Vomiting—Betamethasone—multiple sclerosis	0.000149	0.000682	CcSEcCtD
Propranolol—Decreased appetite—Methotrexate—multiple sclerosis	0.000148	0.000679	CcSEcCtD
Propranolol—Rash—Dexamethasone—multiple sclerosis	0.000148	0.000676	CcSEcCtD
Propranolol—Rash—Betamethasone—multiple sclerosis	0.000148	0.000676	CcSEcCtD
Propranolol—Dermatitis—Dexamethasone—multiple sclerosis	0.000148	0.000676	CcSEcCtD
Propranolol—Dermatitis—Betamethasone—multiple sclerosis	0.000148	0.000676	CcSEcCtD
Propranolol—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000147	0.000674	CcSEcCtD
Propranolol—Fatigue—Methotrexate—multiple sclerosis	0.000147	0.000673	CcSEcCtD
Propranolol—Asthenia—Prednisone—multiple sclerosis	0.000147	0.00067	CcSEcCtD
Propranolol—Pain—Methotrexate—multiple sclerosis	0.000146	0.000668	CcSEcCtD
Propranolol—Diarrhoea—Prednisone—multiple sclerosis	0.00014	0.000639	CcSEcCtD
Propranolol—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.00014	0.000638	CcSEcCtD
Propranolol—Nausea—Dexamethasone—multiple sclerosis	0.000139	0.000637	CcSEcCtD
Propranolol—Nausea—Betamethasone—multiple sclerosis	0.000139	0.000637	CcSEcCtD
Propranolol—Urticaria—Methotrexate—multiple sclerosis	0.000136	0.00062	CcSEcCtD
Propranolol—Dizziness—Prednisone—multiple sclerosis	0.000135	0.000618	CcSEcCtD
Propranolol—Body temperature increased—Methotrexate—multiple sclerosis	0.000135	0.000617	CcSEcCtD
Propranolol—Abdominal pain—Methotrexate—multiple sclerosis	0.000135	0.000617	CcSEcCtD
Propranolol—Vomiting—Prednisone—multiple sclerosis	0.00013	0.000594	CcSEcCtD
Propranolol—Rash—Prednisone—multiple sclerosis	0.000129	0.000589	CcSEcCtD
Propranolol—Dermatitis—Prednisone—multiple sclerosis	0.000129	0.000588	CcSEcCtD
Propranolol—Hypersensitivity—Methotrexate—multiple sclerosis	0.000126	0.000575	CcSEcCtD
Propranolol—Asthenia—Methotrexate—multiple sclerosis	0.000123	0.00056	CcSEcCtD
Propranolol—Nausea—Prednisone—multiple sclerosis	0.000121	0.000555	CcSEcCtD
Propranolol—Diarrhoea—Methotrexate—multiple sclerosis	0.000117	0.000534	CcSEcCtD
Propranolol—Dizziness—Methotrexate—multiple sclerosis	0.000113	0.000516	CcSEcCtD
Propranolol—Vomiting—Methotrexate—multiple sclerosis	0.000109	0.000496	CcSEcCtD
Propranolol—Rash—Methotrexate—multiple sclerosis	0.000108	0.000492	CcSEcCtD
Propranolol—Dermatitis—Methotrexate—multiple sclerosis	0.000108	0.000492	CcSEcCtD
Propranolol—Nausea—Methotrexate—multiple sclerosis	0.000101	0.000464	CcSEcCtD
Propranolol—ABCB1—Metabolism—CYP24A1—multiple sclerosis	2.73e-05	0.000351	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—CYP27B1—multiple sclerosis	2.73e-05	0.000351	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—CCL3—multiple sclerosis	2.72e-05	0.000351	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—CXCL10—multiple sclerosis	2.7e-05	0.000347	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—CCR5—multiple sclerosis	2.69e-05	0.000346	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—IL2RA—multiple sclerosis	2.65e-05	0.000341	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—CXCL10—multiple sclerosis	2.64e-05	0.00034	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—PTGER4—multiple sclerosis	2.62e-05	0.000337	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—CCL5—multiple sclerosis	2.62e-05	0.000337	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—RRM1—multiple sclerosis	2.59e-05	0.000333	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—PGR—multiple sclerosis	2.58e-05	0.000332	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	2.57e-05	0.000331	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	2.57e-05	0.000331	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—CCL5—multiple sclerosis	2.56e-05	0.000329	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—GPC5—multiple sclerosis	2.56e-05	0.000329	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—CXCR3—multiple sclerosis	2.53e-05	0.000326	CbGpPWpGaD
Propranolol—SLC22A2—Neuronal System—MAPK1—multiple sclerosis	2.53e-05	0.000325	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—CD28—multiple sclerosis	2.51e-05	0.000323	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—TYK2—multiple sclerosis	2.5e-05	0.000322	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—CCL5—multiple sclerosis	2.5e-05	0.000322	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—GPC5—multiple sclerosis	2.5e-05	0.000321	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—CCR2—multiple sclerosis	2.46e-05	0.000317	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—CD86—multiple sclerosis	2.4e-05	0.000309	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—SRM—multiple sclerosis	2.39e-05	0.000307	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—CCL5—multiple sclerosis	2.38e-05	0.000306	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—CCL5—multiple sclerosis	2.36e-05	0.000304	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—CCR5—multiple sclerosis	2.36e-05	0.000303	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—GPC5—multiple sclerosis	2.35e-05	0.000303	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—CCL5—multiple sclerosis	2.32e-05	0.000299	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—IL2RA—multiple sclerosis	2.32e-05	0.000299	CbGpPWpGaD
Propranolol—HTR1B—GPCR downstream signaling—POMC—multiple sclerosis	2.31e-05	0.000298	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—CCR5—multiple sclerosis	2.31e-05	0.000297	CbGpPWpGaD
Propranolol—ADRB3—GPCR downstream signaling—IL2—multiple sclerosis	2.29e-05	0.000295	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—CNR1—multiple sclerosis	2.27e-05	0.000293	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—CCL5—multiple sclerosis	2.27e-05	0.000292	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—IL2RA—multiple sclerosis	2.27e-05	0.000292	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—CCR5—multiple sclerosis	2.25e-05	0.00029	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—IL2RA—multiple sclerosis	2.22e-05	0.000286	CbGpPWpGaD
Propranolol—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.21e-05	0.000285	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—SPP1—multiple sclerosis	2.19e-05	0.000282	CbGpPWpGaD
Propranolol—SLC22A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.19e-05	0.000282	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	2.18e-05	0.000281	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	2.18e-05	0.000281	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—BCHE—multiple sclerosis	2.18e-05	0.00028	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—BCHE—multiple sclerosis	2.18e-05	0.00028	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CCL3—multiple sclerosis	2.17e-05	0.000279	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—CCR5—multiple sclerosis	2.14e-05	0.000275	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.13e-05	0.000274	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—CCR5—multiple sclerosis	2.13e-05	0.000274	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CCL3—multiple sclerosis	2.12e-05	0.000273	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—RRM1—multiple sclerosis	2.12e-05	0.000273	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—IL2RA—multiple sclerosis	2.11e-05	0.000271	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—POMC—multiple sclerosis	2.1e-05	0.00027	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—IL2RA—multiple sclerosis	2.1e-05	0.00027	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—CCR5—multiple sclerosis	2.09e-05	0.000269	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—PTGER4—multiple sclerosis	2.09e-05	0.000269	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—IL2—multiple sclerosis	2.08e-05	0.000268	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CCL3—multiple sclerosis	2.08e-05	0.000267	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—RRM1—multiple sclerosis	2.07e-05	0.000266	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—IL2RA—multiple sclerosis	2.06e-05	0.000265	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—PGR—multiple sclerosis	2.06e-05	0.000265	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—CCL2—multiple sclerosis	2.06e-05	0.000264	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—CCR5—multiple sclerosis	2.05e-05	0.000263	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—CXCL10—multiple sclerosis	2.05e-05	0.000263	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—PTGER4—multiple sclerosis	2.04e-05	0.000263	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—IL2RA—multiple sclerosis	2.02e-05	0.00026	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CXCR3—multiple sclerosis	2.02e-05	0.00026	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—PGR—multiple sclerosis	2.01e-05	0.000259	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.01e-05	0.000259	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CD28—multiple sclerosis	2e-05	0.000257	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—PTGER4—multiple sclerosis	2e-05	0.000257	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—GPC5—multiple sclerosis	1.99e-05	0.000257	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CXCR3—multiple sclerosis	1.97e-05	0.000254	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—PGR—multiple sclerosis	1.97e-05	0.000253	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CCR2—multiple sclerosis	1.96e-05	0.000252	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CD28—multiple sclerosis	1.95e-05	0.000251	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—RRM1—multiple sclerosis	1.95e-05	0.000251	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—APOE—multiple sclerosis	1.94e-05	0.000249	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CXCR3—multiple sclerosis	1.93e-05	0.000248	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CCR2—multiple sclerosis	1.92e-05	0.000247	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CD28—multiple sclerosis	1.91e-05	0.000246	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.91e-05	0.000246	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.91e-05	0.000245	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CCR2—multiple sclerosis	1.88e-05	0.000241	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.87e-05	0.00024	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—TYK2—multiple sclerosis	1.87e-05	0.00024	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—POMC—multiple sclerosis	1.84e-05	0.000237	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CNR1—multiple sclerosis	1.81e-05	0.000233	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—POMC—multiple sclerosis	1.8e-05	0.000232	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—CD86—multiple sclerosis	1.79e-05	0.00023	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.78e-05	0.000229	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CNR1—multiple sclerosis	1.77e-05	0.000228	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—CCL5—multiple sclerosis	1.76e-05	0.000227	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—POMC—multiple sclerosis	1.76e-05	0.000227	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—CD80—multiple sclerosis	1.75e-05	0.000225	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CNR1—multiple sclerosis	1.73e-05	0.000223	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.73e-05	0.000222	CbGpPWpGaD
Propranolol—HTR1B—GPCR downstream signaling—IL2—multiple sclerosis	1.71e-05	0.00022	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.68e-05	0.000216	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.68e-05	0.000216	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—POMC—multiple sclerosis	1.67e-05	0.000215	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—POMC—multiple sclerosis	1.66e-05	0.000214	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.65e-05	0.000213	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.65e-05	0.000212	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—CCL2—multiple sclerosis	1.64e-05	0.000211	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—POMC—multiple sclerosis	1.64e-05	0.000211	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—SPP1—multiple sclerosis	1.63e-05	0.00021	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CXCL10—multiple sclerosis	1.63e-05	0.00021	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—CCL2—multiple sclerosis	1.63e-05	0.00021	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—CCL2—multiple sclerosis	1.6e-05	0.000206	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—POMC—multiple sclerosis	1.6e-05	0.000206	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CXCL10—multiple sclerosis	1.59e-05	0.000205	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—MAPK1—multiple sclerosis	1.59e-05	0.000205	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—CCR5—multiple sclerosis	1.59e-05	0.000204	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—BCHE—multiple sclerosis	1.58e-05	0.000203	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.57e-05	0.000203	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—CCL2—multiple sclerosis	1.57e-05	0.000201	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—IL2RA—multiple sclerosis	1.56e-05	0.000201	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CXCL10—multiple sclerosis	1.56e-05	0.000201	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—IL2—multiple sclerosis	1.55e-05	0.0002	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.54e-05	0.000198	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—BCHE—multiple sclerosis	1.49e-05	0.000191	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—TYK2—multiple sclerosis	1.49e-05	0.000191	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—TYK2—multiple sclerosis	1.48e-05	0.00019	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—TYK2—multiple sclerosis	1.45e-05	0.000187	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—APOE—multiple sclerosis	1.44e-05	0.000186	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CD86—multiple sclerosis	1.43e-05	0.000183	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—TYK2—multiple sclerosis	1.42e-05	0.000183	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.41e-05	0.000182	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CCL5—multiple sclerosis	1.4e-05	0.000181	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CD86—multiple sclerosis	1.39e-05	0.000179	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CCL5—multiple sclerosis	1.37e-05	0.000177	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CD86—multiple sclerosis	1.36e-05	0.000175	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—IL2—multiple sclerosis	1.36e-05	0.000175	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CCL5—multiple sclerosis	1.34e-05	0.000173	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—IL2—multiple sclerosis	1.33e-05	0.000171	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—APOE—multiple sclerosis	1.31e-05	0.000169	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—APOE—multiple sclerosis	1.31e-05	0.000168	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—CD80—multiple sclerosis	1.31e-05	0.000168	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—IL2—multiple sclerosis	1.3e-05	0.000168	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—SPP1—multiple sclerosis	1.3e-05	0.000167	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.29e-05	0.000166	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.28e-05	0.000165	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.28e-05	0.000164	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—SPP1—multiple sclerosis	1.27e-05	0.000164	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CCR5—multiple sclerosis	1.26e-05	0.000163	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—IL2RA—multiple sclerosis	1.25e-05	0.00016	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—SPP1—multiple sclerosis	1.24e-05	0.00016	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—POMC—multiple sclerosis	1.24e-05	0.00016	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CCR5—multiple sclerosis	1.24e-05	0.000159	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—IL2—multiple sclerosis	1.24e-05	0.000159	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—IL2—multiple sclerosis	1.23e-05	0.000158	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—IL6—multiple sclerosis	1.22e-05	0.000158	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—IL2RA—multiple sclerosis	1.22e-05	0.000157	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.22e-05	0.000157	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—CCL2—multiple sclerosis	1.21e-05	0.000156	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—IL2—multiple sclerosis	1.21e-05	0.000156	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CCR5—multiple sclerosis	1.21e-05	0.000156	CbGpPWpGaD
Propranolol—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.2e-05	0.000154	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—IL2RA—multiple sclerosis	1.19e-05	0.000153	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—BCHE—multiple sclerosis	1.19e-05	0.000153	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—MAPK1—multiple sclerosis	1.19e-05	0.000153	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—IL2—multiple sclerosis	1.18e-05	0.000152	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—MMP9—multiple sclerosis	1.16e-05	0.00015	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—APOE—multiple sclerosis	1.15e-05	0.000148	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—POMC—multiple sclerosis	1.13e-05	0.000145	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—APOE—multiple sclerosis	1.13e-05	0.000145	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—POMC—multiple sclerosis	1.12e-05	0.000145	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.12e-05	0.000144	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—TYK2—multiple sclerosis	1.1e-05	0.000142	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.1e-05	0.000142	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—APOE—multiple sclerosis	1.1e-05	0.000142	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CD80—multiple sclerosis	1.04e-05	0.000134	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—STAT3—multiple sclerosis	1.04e-05	0.000133	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—ALB—multiple sclerosis	1.03e-05	0.000132	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—ALB—multiple sclerosis	1.03e-05	0.000132	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CD80—multiple sclerosis	1.02e-05	0.000131	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1e-05	0.000129	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CD80—multiple sclerosis	9.95e-06	0.000128	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—POMC—multiple sclerosis	9.88e-06	0.000127	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CCL2—multiple sclerosis	9.67e-06	0.000124	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—POMC—multiple sclerosis	9.67e-06	0.000124	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—MYC—multiple sclerosis	9.62e-06	0.000124	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—TGFB1—multiple sclerosis	9.6e-06	0.000124	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—BCHE—multiple sclerosis	9.49e-06	0.000122	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—APOE—multiple sclerosis	9.48e-06	0.000122	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—MAPK1—multiple sclerosis	9.46e-06	0.000122	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CCL2—multiple sclerosis	9.46e-06	0.000122	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—POMC—multiple sclerosis	9.45e-06	0.000122	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—MAPK1—multiple sclerosis	9.42e-06	0.000121	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—MAPK1—multiple sclerosis	9.25e-06	0.000119	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CCL2—multiple sclerosis	9.25e-06	0.000119	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—IL2—multiple sclerosis	9.17e-06	0.000118	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—IL6—multiple sclerosis	9.13e-06	0.000117	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—MAPK1—multiple sclerosis	9.05e-06	0.000116	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—APOE—multiple sclerosis	8.95e-06	0.000115	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—TYK2—multiple sclerosis	8.78e-06	0.000113	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—MMP9—multiple sclerosis	8.68e-06	0.000112	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—TYK2—multiple sclerosis	8.59e-06	0.000111	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—TYK2—multiple sclerosis	8.4e-06	0.000108	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—POMC—multiple sclerosis	8.14e-06	0.000105	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—STAT3—multiple sclerosis	7.72e-06	9.93e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—POMC—multiple sclerosis	7.69e-06	9.9e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—ALB—multiple sclerosis	7.42e-06	9.55e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—APOE—multiple sclerosis	7.33e-06	9.43e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—BCHE—multiple sclerosis	7.32e-06	9.42e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—IL2—multiple sclerosis	7.31e-06	9.4e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—IL6—multiple sclerosis	7.27e-06	9.35e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—IL6—multiple sclerosis	7.23e-06	9.31e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—MYC—multiple sclerosis	7.17e-06	9.23e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—TGFB1—multiple sclerosis	7.16e-06	9.21e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—APOE—multiple sclerosis	7.15e-06	9.2e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—IL2—multiple sclerosis	7.15e-06	9.19e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—IL6—multiple sclerosis	7.11e-06	9.15e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—MAPK1—multiple sclerosis	7.02e-06	9.03e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—ALB—multiple sclerosis	7.01e-06	9.02e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—IL2—multiple sclerosis	6.99e-06	8.99e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—IL6—multiple sclerosis	6.95e-06	8.95e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MMP9—multiple sclerosis	6.91e-06	8.9e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MMP9—multiple sclerosis	6.76e-06	8.7e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—APOE—multiple sclerosis	6.74e-06	8.67e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MMP9—multiple sclerosis	6.61e-06	8.51e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—POMC—multiple sclerosis	6.29e-06	8.1e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—STAT3—multiple sclerosis	6.15e-06	7.91e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—POMC—multiple sclerosis	6.14e-06	7.9e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—STAT3—multiple sclerosis	6.01e-06	7.74e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—STAT3—multiple sclerosis	5.88e-06	7.57e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—POMC—multiple sclerosis	5.79e-06	7.45e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—ALB—multiple sclerosis	5.74e-06	7.38e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MYC—multiple sclerosis	5.71e-06	7.35e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—APOE—multiple sclerosis	5.71e-06	7.35e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—TGFB1—multiple sclerosis	5.7e-06	7.33e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—ALB—multiple sclerosis	5.6e-06	7.21e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MAPK1—multiple sclerosis	5.59e-06	7.19e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MYC—multiple sclerosis	5.59e-06	7.19e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—TGFB1—multiple sclerosis	5.57e-06	7.17e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MAPK1—multiple sclerosis	5.47e-06	7.03e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MYC—multiple sclerosis	5.46e-06	7.03e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—TGFB1—multiple sclerosis	5.45e-06	7.01e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—IL6—multiple sclerosis	5.39e-06	6.94e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MAPK1—multiple sclerosis	5.35e-06	6.88e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—ALB—multiple sclerosis	5.28e-06	6.79e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—POMC—multiple sclerosis	4.9e-06	6.31e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—ALB—multiple sclerosis	4.47e-06	5.75e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—APOE—multiple sclerosis	4.41e-06	5.67e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—IL6—multiple sclerosis	4.29e-06	5.52e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—IL6—multiple sclerosis	4.2e-06	5.4e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—IL6—multiple sclerosis	4.11e-06	5.28e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—POMC—multiple sclerosis	3.79e-06	4.87e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ALB—multiple sclerosis	3.45e-06	4.44e-05	CbGpPWpGaD
